Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activity

Interleukin 2 Receptor ◽

In vitro and in vivo effects of BT563, an anti-interleukin-2 receptor monoclonal antibody

Transplant International ◽

10.1111/j.1432-2277.1994.tb01442.x ◽

1994 ◽

Vol 7 (s1) ◽

pp. 556-558 ◽

Cited By ~ 6

Author(s):

T. VanGelder ◽

C. R. Daane ◽

L. M. B. Vaessen ◽

C. J. Hesse ◽

W. Weimar ◽

...

Keyword(s):

Monoclonal Antibody ◽

Interleukin 2 ◽

Interleukin 2 Receptor ◽

In Vivo Effects ◽

CYCLOSPORINE AND ANTI-INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY THERAPY SUPPRESS ACCELERATED REJECTION OF RAT CARDIAC ALLOGRAFTS THROUGH DIFFERENT EFFECTOR MECHANISMS

Transplantation Journal ◽

10.1097/00007890-199002000-00037 ◽

1990 ◽

Vol 49 (2) ◽

pp. 416-421 ◽

Cited By ~ 41

Author(s):

WAYNE W. HANCOCK ◽

ROSSELLA DISTEFANO ◽

PATRICIA BRAUN ◽

ROBERT T. SCHWEIZER ◽

NICHOLAS L. TILNEY ◽

...

Keyword(s):

Monoclonal Antibody ◽

Interleukin 2 ◽

Antibody Therapy ◽

Interleukin 2 Receptor ◽

Cardiac Allografts ◽

Receptor Monoclonal Antibody ◽

Effector Mechanisms

Anti-Interleukin-2 Receptor Monoclonal Antibody Therapy Supports a Role for Thl-Like Cells in HgCl2-Induced Autoimmunity in Rats

Scandinavian Journal of Immunology ◽

10.1111/j.1365-3083.1993.tb03311.x ◽

1993 ◽

Vol 37 (4) ◽

pp. 406-412 ◽

Cited By ~ 16

Author(s):

D. DUBEY ◽

J. KUHN ◽

M. C. VIAL ◽

P. DRUET ◽

B. BELLON

Keyword(s):

Monoclonal Antibody ◽

Interleukin 2 ◽

Antibody Therapy ◽

Interleukin 2 Receptor ◽

Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy

Journal of Clinical Immunology ◽

10.1007/s10875-011-9624-5 ◽

2012 ◽

Vol 32 (3) ◽

pp. 632-646 ◽

Cited By ~ 27

Author(s):

Caroline Veuillen ◽

Thérèse Aurran-Schleinitz ◽

Rémy Castellano ◽

Jérôme Rey ◽

Françoise Mallet ◽

...

Keyword(s):

Monoclonal Antibody ◽

Nk Cells ◽

Nk Cell ◽

Antibody Therapy ◽

Cell Cytotoxicity ◽

Nk Cell Cytotoxicity

Complement Activation by Anti-Acetylcholine Receptor Monoclonal Antibody in Vitro Correlates with Potency of EAMG Response in Vivo

Annals of the New York Academy of Sciences ◽

10.1111/j.1749-6632.1987.tb51351.x ◽

1987 ◽

Vol 505 (1 Myasthenia Gr) ◽

pp. 725-727 ◽

Cited By ~ 4

Author(s):

BONITA L. DuPONT ◽

DAVID P. RICHMAN

Keyword(s):

Monoclonal Antibody ◽

Acetylcholine Receptor ◽

Complement Activation ◽

Receptor Monoclonal Antibody ◽

Anti Acetylcholine

Immunoprophylaxis with basiliximab, a chimeric anti[ndash ]interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients

Liver Transplantation ◽

10.1053/jlts.2002.30882 ◽

2002 ◽

Vol 8 (2) ◽

pp. 123-131 ◽

Cited By ~ 71

Author(s):

Y Calmus

Keyword(s):

Monoclonal Antibody ◽

Liver Transplant ◽

Triple Therapy ◽

Interleukin 2 ◽

Transplant Recipients ◽

Interleukin 2 Receptor ◽

Liver Transplant Recipients ◽

Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody

Annals of Neurology ◽

10.1002/ana.20287 ◽

2004 ◽

Vol 56 (6) ◽

pp. 864-867 ◽

Cited By ~ 129

Author(s):

John W. Rose ◽

Hilary E. Watt ◽

Andrea T. White ◽

Noel G. Carlson

Keyword(s):

Multiple Sclerosis ◽

Monoclonal Antibody ◽

Interleukin 2 ◽

Interleukin 2 Receptor ◽

Anti-human interleukin 2 receptor monoclonal antibody isotypic switching: Chimeric rat-human antibodies

Human Immunology ◽

10.1016/0198-8859(90)90037-p ◽

1990 ◽

Vol 29 (4) ◽

pp. 233-246

Author(s):

E.D. Carosella ◽

M. Latour ◽

Y. Jacques ◽

J.P. Soulillou

Keyword(s):

Monoclonal Antibody ◽

Interleukin 2 ◽

Human Antibodies ◽

Interleukin 2 Receptor ◽

Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody

Clinical and Experimental Dermatology ◽

10.1046/j.1365-2230.2000.00612.x ◽

2000 ◽

Vol 25 (3) ◽

pp. 195-197 ◽

Cited By ~ 51

Author(s):

C. M. Owen ◽

P. V. Harrison

Keyword(s):

Monoclonal Antibody ◽

Successful Treatment ◽

Interleukin 2 ◽

Severe Psoriasis ◽

Interleukin 2 Receptor ◽

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary

Journal of Oncology Practice ◽

10.1200/jop.2015.007898 ◽

2016 ◽

Vol 12 (2) ◽

pp. 180-181 ◽

Cited By ~ 14

Author(s):

Carmen J. Allegra ◽

R. Bryan Rumble ◽

Richard L. Schilsky

Keyword(s):

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Antibody Therapy ◽

Growth Factor Receptor ◽

Metastatic Colorectal Carcinoma ◽

Ras Gene ◽

Epidermal Growth ◽

American Society ◽